title: [Beta blockers in hypertension treatment Will stepping back come soon?].
authors.affiliation: Instituts für Qualität und Wirtschaftlichkeit in der Medizin.
authors.forename: Peter T
authors.initials: PT
authors.lastname: Sawicki
authors.forename: Manfred
authors.initials: M
authors.lastname: Anlauf
authors.forename: Hermann
authors.initials: H
authors.lastname: Haller
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000367:Age Factors; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001262:Atenolol / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D015201:Meta-Analysis as Topic; D008790:Metoprolol / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D012307:Risk Factors; D013565:Sympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D013565:Sympatholytics; D001262:Atenolol; D008790:Metoprolol